Labcorp Holdings Stock Drops Amid Medicare Reimbursement Rate Reduction
On September 22, Labcorp Holdings (NYSE: LH) stock fell by approximately 3.3% after the Centers for Medicare & Medicaid Services announced a plan to reduce reimbursement rates for lab work starting January 1, 2027. The new policy will cut CMS payments by up to 15%, which is expected to save taxpayers $1 billion annually but could significantly impact Labcorp's revenue stream. Labcorp highlighted in its latest SEC filing that Medicare and Medicaid reimbursements account for about 8% of the company’s total revenue, making it vulnerable to such policy changes. A full 15% reduction would equate to a potential annual loss of approximately 1.2% in revenue. With possible reductions continuing through 2029, Labcorp could face up to a 3.6% decline in business. The market appears to have already priced in the worst-case scenario for Labcorp as its stock dropped nearly in line with this potential impact today.
Tickers: $LH
Topics: cms_regulation healthcare lab_services